Diagnose & select
Review the asset portfolio, establish scored selection criteria and choose two live cases.
Research valorisation & technology transfer
From research assets
to investable possibilities.
We turn research assets into fundable projects and investable companies by building the market evidence, business model and roadmap around the technology.
Research · IP · Market · FundingFor research institutions & innovation teams
Choose the asset.
Build the business case.
A technically strong asset needs a credible route to adoption. We work with research teams, technology-transfer offices and founders to decide what to develop, who could use it and what evidence the next funding decision requires.
The result is a practical pathway towards industrial collaboration, licensing, a spin-off or private capital, with the team involved in building it.
What we connect
- 01Technology maturity, IP position and validation requirements
- 02Customer needs, use cases and evidence of demand
- 03Business-model options and routes to commercialisation
- 04Milestones, decision gates, owners and funding sequence
- 05Industrial partners and specialist capabilities
A practical first engagement
12 weeks.
Two real assets.
One small team.
Build the method through live decisions.
Start with a selected pair of assets. Work through the evidence, test the routes to market and leave the institution with a toolkit it can apply again.
Explore the first engagement01
A route from assessment to handover
Decide on live cases
Test use cases, demand and commercialisation options with relevant market counterparts.
Guided application
Develop the business model and technology-to-market roadmap, including evidence and funding gates.
Handover & toolkit
Transfer the decision process, asset roadmaps and reusable tools to the institution’s team.
A starting format from our research-valorisation programme. Asset selection and scope are agreed with the institution before launch.
02
The business layer around the science
A pathway the next
decision-maker can use.
The roadmap translates technical progress into the choices an industrial partner, funder or investor needs to assess.
Evidence before commitment.
Asset scoring, IP and validation review, demand testing and gaps to address before further investment.
The route that fits the asset.
Compare licensing, collaboration and spin-off pathways. Build a market narrative and economic logic around the selected route.
Milestones that support capital decisions.
Sequence validation, market and operating milestones, with the documentation needed for programme and investor conversations.
Deep tech and robotics in a portfolio?
EV Multiplier connects research and technology assets to recurring revenue, operating readiness and a more defensible enterprise-value thesis.
Explore EV Multiplier